, /PRNewswire/ -- Yatsen Group (NYSE: YSG), a world-class beauty innovation pioneer, recently announced a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership integrates Yatsen's rigorous scientific infrastructure with the world's leading prestige beauty retailer, marking a significant milestone in Yatsen's continuing evolution into a global beauty technology powerhouse.
Perfect Diary officially lands at Sephora China The collaboration will see Perfect Diary's premium, science-backed portfolio of products making its milestone debut across Sephora's extensive retail network of around 300 outlets, including Tier 1 hubs such as Beijing, Shanghai, Guangzhou, and Shenzhen. This expansion reflects a broader shift in the Chinese beauty market, where sophisticated consumers increasingly prioritize proven efficacy and technological excellence.
Since 2020, Yatsen has invested approximately $100 million (RMB 700 million) in R&D, establishing a robust global innovation ecosystem anchored by advanced research centers in China and Europe.
This commitment to scientific innovation by Yatsen Group is epitomized by the core product lineups driving Perfect Diary's entry into Sephora. As breakthrough products blending biotechnology with beauty, the Perfect Diary Biolip Essence Lipstick 3.0 and Biolip Essence Matte Lipstick 3.0 utilize exclusive patented technology to mimic the skin's biological composition.This creates a functional film on the skin's surface that enhances makeup longevity and reinforces the protective barrier, achieving a seamless fusion of high-performance color and clinical-proved anti-wrinkle skincare benefits.
Concurrently, the Perfect Diary Translucent Blurring Setting Powder features the exclusive Smartlock™ material technology developed jointly with the team at the Shanghai Institute of Ceramics, Chinese Academy of Sciences (SICCAS), enabling targeted and precise oil absorption.
"We are honored to partner with Sephora, a global leader that shares our commitment to setting the highest standards for beauty retail," said David (Jinfeng) Huang, Founder, Chairman, and CEO of Yatsen Group. "This collaboration validates our multi-year strategic pivot toward science-led premiumization. By pairing our deep R&D insights with Sephora's prestige omnichannel network, we are redefining the future of beauty for discerning consumers nationwide."
The partnership also serves as a critical foundation for Yatsen's accelerating internationalization strategy. Future initiatives include expanding Perfect Diary's footprint into Hong Kong SAR and other global markets, further showcasing China's emergence as a premier hub for global beauty innovation.
About Yatsen Group
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
Website: www.yatsenglobal.com
LinkedIn: www.linkedin.com/company/yatsen
About Sephora
Sephora is the world's leading global prestige beauty retail brand. With 55,000 passionate employees operating in 36 markets, Sephora connects customers and beauty brands within the world's most trusted and dynamic beauty community. We serve a highly engaged community of hundreds of millions of beauty followers across our global omnichannel network of more than 3,400 stores and iconic flagships, and our e-commerce and digital platforms, offering personalized and immersive seamless experiences across every touchpoint. With our curation of close to 500 brands and our own label, Sephora Collection, we offer the most unique and diverse range of prestige beauty products, tailored to our customers' needs from fragrance to make-up, haircare, skincare and beyond, as we constantly reimagine the world of prestige beauty.
Since our inception in 1969 in Limoges, France, and as part of the LVMH Group since 1997, we have been disrupting the prestige beauty retail industry. Today, we continue to break with convention to drive our mission: champion a world of inspiration and inclusion where everyone can celebrate their beauty.
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC") on April 29, 2026.
The annual report is available on the Company's investor relations website at ir.yatsenglobal.com and on the SEC's website at https://www.sec.gov/. The Company will provide hard copies of the annual report, free of charge, to its shareholders and ADS holders upon written request. Requests should be directed to Investor Relations Department, Yatsen Holding Limited, Floor 39, Poly Development Plaza, No. 832 Yue Jiang Zhong Road, Haizhu District, Guangzhou 510335, People's Republic of China.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com/.
, /PRNewswire/ -- In a significant shift reshaping the global beauty industry, Chinese domestic cosmetics brands have captured nearly 60% of the world's second-largest beauty market. This shift is being driven by unprecedented investments in scientific innovation, as well as rapidly evolving consumer expectations. Yatsen Group, one of China's leading beauty companies, today highlighted how its approximately $100 million (RMB 700 million) in R&D investment since 2020 exemplifies the industry's transformation from price-based competition to technology-driven excellence.
Cheng Jing, Chief Scientific Officer of Yatsen Group, during an interview with CGTN (China Global Television Network)
Yatsen Global Innovation R&D Center Over the past decade, Chinese beauty companies have fundamentally strengthened their competitive position, with market share surging from 43% in 2015, according to Frost & Sullivan, to 57% in 2024, according to Xinhua News. This growth reflects a broader consumer evolution: Chinese beauty shoppers are increasingly prioritizing proven efficacy, scientific credibility, and innovation, a shift that domestic brands have actively capitalized on by ramping up investment in R&D and innovation to respond quickly to changing preferences.
As a result, Chinese cosmetics brands are moving away from reliance on cost competition toward building a long-term technological and brand advantage on the global stage.
"This growth is primarily driven by continuous advancements in innovation, brand equity, and product use experience," said Cheng Jing, Chief Scientific Officer of Yatsen Group. "Chinese consumers have become more sophisticated. Their focus has shifted from price to proven efficacy, safety, scientific credibility, and cultural identity."
Importantly, this transformation extends far beyond marketing. Leading Chinese beauty companies are constructing world-class innovation ecosystems.
Yatsen's "1-3-4-6-20" global innovation strategy encompasses three research centers across Shanghai, Guangzhou, and Toulouse, France, with over half of its R&D team holding master's or PhD degrees. The company maintains six joint research laboratories and more than 20 collaborative programs with prestigious institutions including Saint-Louis Hospital in France, as well as Ruijin Hospital, Sun Yat-sen University and Fudan University in China.
"The industry is moving from supply-chain-driven 'product globalization' to innovation-led 'brand globalization,'" added Cheng Jing. "Looking ahead, our goal is to be a world-class beauty innovation pioneer, utilizing a resilient supply chain and 'Glocal' agility to meet the needs of sophisticated consumers worldwide."
This scientific infrastructure addresses what industry analysts identify as the new consumer mandate: products that deliver measurable results backed by rigorous research.
This focus is reflected in Yatsen's portfolio: Perfect Diary leads the emerging "makeup skinification" trend, DR.WU delivers clinic-grade skin renewal, Galénic focuses on cellular-level anti-aging science and Eve Lom leverages advanced neuroscience for emotional skincare benefits.
Global Ambitions, Local Insights
The domestic market success is proving to be a launchpad for international expansion. Since 2021, Yatsen's flagship brand Perfect Diary has gained traction in Southeast Asia and Japan. Its loose powder has consistently ranked among the top three in its category on major e-commerce platforms, according to data from Qoo10 Japan, Amazon Japan, Shopee Vietnam, and TikTok Vietnam—demonstrating that Chinese innovation can compete on performance.
According to one full year of continuous tracking data by Frost & Sullivan, Perfect Diary Biolip Essence Lipstick has been officially recognized as the top-selling lipstick SKU by a Chinese brand worldwide. This achievement stands as a significant milestone showcasing the global rise of technological innovation among Chinese brands.
According to CGTN, Chinese beauty companies are well positioned to benefit from the global shift toward a dual emphasis on efficacy and emotional value. With complete innovation capabilities spanning raw materials to finished products, and supply chain agility that enables rapid response to market trends, domestic brands have transformed former weaknesses into competitive advantages.
About Yatsen Group
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it will release its unaudited financial results for the first quarter of 2026, on Tuesday, May 26, 2026, before the open of the U.S. markets.
The Company's management will hold a conference call on Tuesday, May 26, 2026 at 7:30 A.M. U.S. Eastern Time (7:30 P.M. Beijing/Hong Kong Time) to discuss the financial results. Listeners may access the call by dialing the following numbers:
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong (toll free):
800-905-945
Hong Kong:
+852-3018-4992
A live and archived webcast of the conference call will be available on the Company's investor relations website at http://ir.yatsenglobal.com.
A replay of the conference call will be accessible by phone one hour after the conclusion of the live call at the following numbers, until June 2, 2026:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
4359154
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced the participation of Hillhouse in the Company's previously announced private placement of RMB-denominated convertible senior notes and warrants (the "Transaction"), and the completion of the first tranche of the Transaction.
Certain affiliates of Hillhouse have joined the investment vehicle for the Transaction (the "Purchaser") as a co-investor, alongside Trustar Capital and Mr. Jinfeng Huang, the Company's founder, Chairman and Chief Executive Officer. The Company and the Purchaser have entered into an amendment to the original note purchase agreement to reflect the expanded investor base.
The closing of the first tranche of the notes (the "First Note") and the corresponding warrants occurred on May 21, 2026. Subject to the satisfaction of applicable closing conditions, the second tranche of the notes is currently expected to be issued later this year. The total aggregate principal amount of the two equal tranches of notes remains unchanged at equivalent to approximately US$120 million. The Company continues to intend to use the net proceeds from the Transaction for product research and development, global supply chain integration, overseas market expansion, strategic mergers and acquisitions, and general corporate purposes.
Mr. Jinfeng Huang, Founder, Chairman and CEO of Yatsen, stated: "We are pleased to welcome Hillhouse's participation in the Transaction. As one of Yatsen's largest and longest-standing shareholders, Hillhouse has supported the Company since 2018. Their continued commitment, together with Trustar Capital and my personal participation, reflects strong confidence in Yatsen's long-term value and strategic direction. With the completion of the first tranche, we are better positioned to execute our growth strategy and create lasting value for shareholders over the long term."
The issuance of the securities under the Transaction has not been registered and is exempt from registration under the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom.
For more information, please visit http://ir.yatsenglobal.com/.
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.
First Quarter 2026 Highlights
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. Total net revenues from Skincare Brands[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period. Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."
Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."
First Quarter 2026 Financial Results
Net Revenues
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]
Gross Profit and Gross Margin
Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.
Operating Expenses
Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.
Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency. Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform. General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat. Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount. Loss / Income from Operations
Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.
Non-GAAP loss from operations[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin[5] was 8.3%, as compared with 1.8% for the prior year period.
Net Loss / Income
Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.
Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.
Balance Sheet and Cash Flow
As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.
Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.
Business Outlook
For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.
Exchange Rate
This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.
[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.
[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.
[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.
[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.
[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.
[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.
[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.
Conference Call Information
The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong, SAR (toll free):
800-905-945
Hong Kong, SAR:
+852-3018-4992
The replay will be accessible through Tuesday, June 2, by dialing the following numbers:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
4359154
A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
Use of Non-GAAP Financial Measures
The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.
However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
(All amounts in thousands, except for share, per share data or otherwise noted)
December 31,
March 31,
March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Assets
Current assets
Cash and cash equivalents
765,379
876,144
127,014
Restricted Cash
42,117
58,036
8,413
Short-term investments
246,008
-
-
Accounts receivable, net
220,870
183,701
26,631
Inventories, net
508,730
573,339
83,117
Prepayments and other current assets
450,970
440,103
63,802
Amounts due from related parties
114
53
8
Total current assets
2,234,188
2,131,376
308,985
Non-current assets
Investments
653,560
667,995
96,839
Property and equipment, net
77,014
71,982
10,435
Goodwill, net
155,029
155,029
22,474
Intangible assets, net
537,509
509,249
73,826
Deferred tax assets
1,435
1,040
151
Right-of-use assets, net
173,915
158,718
23,009
Other non-current assets
14,332
22,151
3,211
Total non-current assets
1,612,794
1,586,164
229,945
Total assets
3,846,982
3,717,540
538,930
Liabilities, redeemable non-controlling interests and shareholders'
equity
Current liabilities
Accounts and notes payable
149,371
154,805
22,442
Advances from customers
28,821
29,480
4,274
Accrued expenses and other liabilities
348,700
322,994
46,824
Amounts due to related parties
21,262
19,412
2,814
Income tax payables
13,690
13,778
1,997
Lease liabilities due within one year
53,435
53,039
7,689
Total current liabilities
615,279
593,508
86,040
Non-current liabilities
Deferred tax liabilities
107,906
106,052
15,374
Lease liabilities
123,157
110,184
15,973
Total non-current liabilities
231,063
216,236
31,347
Total liabilities
846,342
809,744
117,387
Redeemable non-controlling interests
1,337
1,337
194
Shareholders' equity
Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and March 31, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,536,483 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of March 31,
2026)
173
173
25
Treasury shares
(1,250,678)
(1,253,378)
(181,702)
Additional paid-in capital
12,296,367
12,297,001
1,782,691
Statutory reserve
31,527
31,527
4,570
Accumulated deficit
(8,141,545)
(8,202,059)
(1,189,049)
Accumulated other comprehensive income
74,760
45,910
6,657
Total Yatsen Holding Limited shareholders' equity
3,010,604
2,919,174
423,192
Non-controlling interests
(11,301)
(12,715)
(1,843)
Total shareholders' equity
2,999,303
2,906,459
421,349
Total liabilities, redeemable non-controlling interests and
shareholders' equity
3,846,982
3,717,540
538,930
YATSEN HOLDING LIMITED
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Total net revenues
833,533
1,020,986
148,012
Total cost of revenues
(174,406)
(201,797)
(29,254)
Gross profit
659,127
819,189
118,758
Operating expenses:
Fulfilment expenses
(51,843)
(61,138)
(8,863)
Selling and marketing expenses
(553,815)
(737,236)
(106,877)
General and administrative expenses
(64,883)
(80,326)
(11,645)
Research and development expenses
(22,637)
(39,440)
(5,718)
Total operating expenses
(693,178)
(918,140)
(133,103)
Loss from operations
(34,051)
(98,951)
(14,345)
Financial income
10,606
10,741
1,557
Foreign currency exchange gain (loss)
10,664
(3,198)
(464)
Income from equity method investments, net
2,505
12,389
1,796
Other income, net
4,242
18,466
2,677
Loss before income tax expenses
(6,034)
(60,553)
(8,779)
Income tax benefits (expenses)
433
(1,375)
(199)
Net loss
(5,601)
(61,928)
(8,978)
Net loss attributable to non-controlling interests and redeemable non-
controlling interests
298
1,414
205
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Shares used in calculating loss per share (1):
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,837,466,068
1,876,901,662
1,876,901,662
Net loss per Class A and Class B ordinary share
Basic
(0.00)
(0.03)
(0.00)
Diluted
(0.00)
(0.03)
(0.00)
Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)
Basic
(0.06)
(0.64)
(0.09)
Diluted
(0.06)
(0.64)
(0.09)
For the Three Months Ended March 31,
2025
2026
2026
Share-based compensation expenses are included in the
operating expenses as follows:
RMB'000
RMB'000
USD'000
Fulfilment expenses
98
249
36
Selling and marketing expenses
757
148
21
General and administrative expenses
7,731
2,003
290
Research and development expenses
40
1,159
168
Total
8,626
3,559
515
(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each
Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that
are subject to shareholder vote.
YATSEN HOLDING LIMITED
UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Loss from operations
(34,051)
(98,951)
(14,345)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Non-GAAP loss from operations
(14,864)
(84,633)
(12,270)
Net loss
(5,601)
(61,928)
(8,978)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(433)
829
120
Non-GAAP net income (loss)
7,143
(57,250)
(8,301)
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,179
10,473
1,518
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(405)
829
120
Non-GAAP net income (loss) attributable to Yatsen's
shareholders
7,087
(56,122)
(8,138)
Shares used in calculating loss per share:
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,953,491,427
1,876,901,662
1,876,901,662
Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share
Basic
0.00
(0.03)
(0.00)
Diluted
0.00
(0.03)
(0.00)
Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)
Yatsen Announces First Quarter 2026 Financial Results PR Newswire
GUANGZHOU, China, May 26, 2026
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.
First Quarter 2026 Highlights
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period.Total net revenues from Skincare Brands[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period.Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period.Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."
Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."
First Quarter 2026 Financial Results
Net Revenues
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]
Gross Profit and Gross Margin
Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.
Operating Expenses
Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.
Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency.Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform.General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat.Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount.Loss / Income from Operations
Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.
Non-GAAP loss from operations[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin[5] was 8.3%, as compared with 1.8% for the prior year period.
Net Loss / Income
Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.
Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.
Balance Sheet and Cash Flow
As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.
Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.
Business Outlook
For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.
Exchange Rate
This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.
[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.
[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.
[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.
[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.
[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.
[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.
[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.
Conference Call Information
The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong, SAR (toll free):
800-905-945
Hong Kong, SAR:
+852-3018-4992
The replay will be accessible through Tuesday, June 2, by dialing the following numbers:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
4359154
A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
Use of Non-GAAP Financial Measures
The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.
However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
(All amounts in thousands, except for share, per share data or otherwise noted)
December 31,
March 31,
March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Assets
Current assets
Cash and cash equivalents
765,379
876,144
127,014
Restricted Cash
42,117
58,036
8,413
Short-term investments
246,008
-
-
Accounts receivable, net
220,870
183,701
26,631
Inventories, net
508,730
573,339
83,117
Prepayments and other current assets
450,970
440,103
63,802
Amounts due from related parties
114
53
8
Total current assets
2,234,188
2,131,376
308,985
Non-current assets
Investments
653,560
667,995
96,839
Property and equipment, net
77,014
71,982
10,435
Goodwill, net
155,029
155,029
22,474
Intangible assets, net
537,509
509,249
73,826
Deferred tax assets
1,435
1,040
151
Right-of-use assets, net
173,915
158,718
23,009
Other non-current assets
14,332
22,151
3,211
Total non-current assets
1,612,794
1,586,164
229,945
Total assets
3,846,982
3,717,540
538,930
Liabilities, redeemable non-controlling interests and shareholders'
equity
Current liabilities
Accounts and notes payable
149,371
154,805
22,442
Advances from customers
28,821
29,480
4,274
Accrued expenses and other liabilities
348,700
322,994
46,824
Amounts due to related parties
21,262
19,412
2,814
Income tax payables
13,690
13,778
1,997
Lease liabilities due within one year
53,435
53,039
7,689
Total current liabilities
615,279
593,508
86,040
Non-current liabilities
Deferred tax liabilities
107,906
106,052
15,374
Lease liabilities
123,157
110,184
15,973
Total non-current liabilities
231,063
216,236
31,347
Total liabilities
846,342
809,744
117,387
Redeemable non-controlling interests
1,337
1,337
194
Shareholders' equity
Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and March 31, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,536,483 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of March 31,
2026)
173
173
25
Treasury shares
(1,250,678)
(1,253,378)
(181,702)
Additional paid-in capital
12,296,367
12,297,001
1,782,691
Statutory reserve
31,527
31,527
4,570
Accumulated deficit
(8,141,545)
(8,202,059)
(1,189,049)
Accumulated other comprehensive income
74,760
45,910
6,657
Total Yatsen Holding Limited shareholders' equity
3,010,604
2,919,174
423,192
Non-controlling interests
(11,301)
(12,715)
(1,843)
Total shareholders' equity
2,999,303
2,906,459
421,349
Total liabilities, redeemable non-controlling interests and
shareholders' equity
3,846,982
3,717,540
538,930
YATSEN HOLDING LIMITED
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Total net revenues
833,533
1,020,986
148,012
Total cost of revenues
(174,406)
(201,797)
(29,254)
Gross profit
659,127
819,189
118,758
Operating expenses:
Fulfilment expenses
(51,843)
(61,138)
(8,863)
Selling and marketing expenses
(553,815)
(737,236)
(106,877)
General and administrative expenses
(64,883)
(80,326)
(11,645)
Research and development expenses
(22,637)
(39,440)
(5,718)
Total operating expenses
(693,178)
(918,140)
(133,103)
Loss from operations
(34,051)
(98,951)
(14,345)
Financial income
10,606
10,741
1,557
Foreign currency exchange gain (loss)
10,664
(3,198)
(464)
Income from equity method investments, net
2,505
12,389
1,796
Other income, net
4,242
18,466
2,677
Loss before income tax expenses
(6,034)
(60,553)
(8,779)
Income tax benefits (expenses)
433
(1,375)
(199)
Net loss
(5,601)
(61,928)
(8,978)
Net loss attributable to non-controlling interests and redeemable non-
controlling interests
298
1,414
205
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Shares used in calculating loss per share (1):
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,837,466,068
1,876,901,662
1,876,901,662
Net loss per Class A and Class B ordinary share
Basic
(0.00)
(0.03)
(0.00)
Diluted
(0.00)
(0.03)
(0.00)
Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)
Basic
(0.06)
(0.64)
(0.09)
Diluted
(0.06)
(0.64)
(0.09)
For the Three Months Ended March 31,
2025
2026
2026
Share-based compensation expenses are included in the
operating expenses as follows:
RMB'000
RMB'000
USD'000
Fulfilment expenses
98
249
36
Selling and marketing expenses
757
148
21
General and administrative expenses
7,731
2,003
290
Research and development expenses
40
1,159
168
Total
8,626
3,559
515
(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each
Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that
are subject to shareholder vote.
YATSEN HOLDING LIMITED
UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Loss from operations
(34,051)
(98,951)
(14,345)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Non-GAAP loss from operations
(14,864)
(84,633)
(12,270)
Net loss
(5,601)
(61,928)
(8,978)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(433)
829
120
Non-GAAP net income (loss)
7,143
(57,250)
(8,301)
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,179
10,473
1,518
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(405)
829
120
Non-GAAP net income (loss) attributable to Yatsen's
shareholders
7,087
(56,122)
(8,138)
Shares used in calculating loss per share:
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,953,491,427
1,876,901,662
1,876,901,662
Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share
Basic
0.00
(0.03)
(0.00)
Diluted
0.00
(0.03)
(0.00)
Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)
Basic
0.08
(0.60)
(0.09)
Diluted
0.07
(0.60)
(0.09)
View original content:https://www.prnewswire.com/news-releases/yatsen-announces-first-quarter-2026-financial-results-302781575.html